Tryp Therapeutics Inc (TRYP) Corporate Media Kit

Market Considerations With the goal to provide physicians with a broader set of tools to treat patients, Tryp is well positioned to capitalize on growth opportunities spanning a range of therapeutic markets. In particular, the global fibro- myalgia therapeutics market represents a sizable opportunity. In 2020, the global fibromyalgia treatment market was valued at $764 million and, due to the limited number of approved therapies, presents unique opportunities for development. With treatment trending upward, the market is expected to grow at a 9.2% CAGR to reach $1.4 billion by 2027 ( https://nnw.fm/kDoGV ).